keyword
https://read.qxmd.com/read/37891020/sirolimus-long-term-tolerability-and-impact-on-kidney-function-in-lung-transplantation-a-single-center-experience
#21
JOURNAL ARTICLE
Ashley A Feist, Mark Mariski, Linda Awdishu, Michelle Bremer, Gordon Yung, Chris Jung, Eugene Golts, Kamyar Afshar
BACKGROUND: After lung transplant, 2 common complications are calcineurin inhibitor (CNI) induced nephrotoxicity and bronchiolitis obliterans syndrome. The objective of this study was to investigate the long-term effects of sirolimus conversion after lung transplantation. METHODS: This was a retrospective cohort study of patients who had undergone lung transplantation at a single center from June 2003 to December 2016. We compared patients converted to a sirolimus-based regimen to those maintained on our standard tacrolimus-based regimen...
October 25, 2023: Transplantation Proceedings
https://read.qxmd.com/read/37887076/chronic-lung-allograft-dysfunction-is-associated-with-significant-disability-after-lung-transplantation-a-burden-of-disease-analysis-in-1025-cases
#22
JOURNAL ARTICLE
Roland Diel, Susanne Simon, Jens Gottlieb
BACKGROUND: Chronic lung allograft dysfunction (CLAD) is the leading cause of death after the first postoperative years of lung transplantation (LTx). OBJECTIVE: To assess the number of disability-adjusted life years (DALYs) per patient with severe CLAD. METHODS: The clinical and demographic data of patients who received their lung transplantation between 2010 and 2020 in the Hanover Medical School (Germany) were evaluated. RESULTS: A total of 1025 lung transplant patients were followed for a median of 51 months (4...
October 12, 2023: Advances in Respiratory Medicine
https://read.qxmd.com/read/37870882/prognostic-value-of-chest-ct-findings-at-bos-diagnosis-in-lung-transplant-recipients
#23
JOURNAL ARTICLE
Anke Van Herck, Hanne Beeckmans, Pieterjan Kerckhof, Annelore Sacreas, Saskia Bos, Janne Kaes, Arno Vanstapel, Bart M Vanaudenaerde, Jan Van Slambrouck, Michaela Orlitová, Xin Jin, Laurens J Ceulemans, Dirk E Van Raemdonck, Arne P Neyrinck, Laurent Godinas, Lieven J Dupont, Geert M Verleden, Adriana Dubbeldam, Walter De Wever, Robin Vos
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) after lung transplantation is characterized by fibrotic small airway remodeling, recognizable on high-resolution computed tomography (HRCT). We studied the prognostic value of key HRCT features at BOS diagnosis after lung transplantation. METHODS: The presence and severity of bronchiectasis, mucous plugging, peribronchial thickening, parenchymal anomalies, and air trapping, summarized in a total severity score, were assessed using a simplified Brody II scoring system on HRCT at BOS diagnosis, in a cohort of 106 bilateral lung transplant recipients transplanted between January 2004 and January 2016...
November 1, 2023: Transplantation
https://read.qxmd.com/read/37818354/monitoring-regulatory-t-cells-as-a-prognostic-marker-in-lung-transplantation
#24
REVIEW
Mohammad Afzal Khan, Christine L Lau, Alexander Sasha Krupnick
Lung transplantation is the major surgical procedure, which restores normal lung functioning and provides years of life for patients suffering from major lung diseases. Lung transplant recipients are at high risk of primary graft dysfunction, and chronic lung allograft dysfunction (CLAD) in the form of bronchiolitis obliterative syndrome (BOS). Regulatory T cell (Treg) suppresses effector cells and clinical studies have demonstrated that Treg levels are altered in transplanted lung during BOS progression as compared to normal lung...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37741923/early-chest-ct-abnormalities-to-predict-the-subsequent-occurrence-of-chronic-lung-allograft-dysfunction
#25
JOURNAL ARTICLE
Paul Habert, Elsa Chetrit, Benjamin Coiffard, Fabienne Bregeon, Pascal Thomas, Anderson Loundou, Julien Bermudez, Martine Reynaud-Gaubert, Jean-Yves Gaubert
INTRODUCTION: Chronic lung allograft dysfunction (CLAD) can take two forms: bronchiolitis obliterans syndrome (BOS) or restrictive allograft syndrome (RAS). The aim was to determine if chest-CT abnormalities after lung transplantation (LTx) could predict CLAD before respiratory functional deterioration. MATERIALS AND METHODS: This monocentric retrospective study analyzed consecutive patients who underwent LTx from January 2015 to December 2018. Initial CT post-LTx (CTi) and a follow-up CT at least 9 months post-LTx (CTf) were reviewed...
September 23, 2023: Insights Into Imaging
https://read.qxmd.com/read/37741317/impact-of-lung-transplantation-on-diastolic-dysfunction-in-recipients-with-pre-transplant-pulmonary-hypertension
#26
JOURNAL ARTICLE
Rishav Aggarwal, Koray N Potel, Scott Jackson, Nicholas T Lemke, Rosemary F Kelly, Matthew Soule, Ilitch Diaz-Gutierrez, Sara J Shumway, Jagadish Patil, Marshall Hertz, Prabhjot S Nijjar, Stephen J Huddleston
OBJECTIVE: Pulmonary hypertension (PH) can cause left ventricular diastolic dysfunction (DD) through ventricular interdependence. Moreover, DD has been linked with adverse outcomes after lung transplant (LTx). The impact of LTx on DD in recipients with pre-transplant PH is not defined. In this cohort, we aimed to assess the prevalence of DD, change in DD after LTx and the impact of DD on LTx outcomes. METHODS: In a large, single center database from January 2011-September 2021, single or bilateral LTx recipients with PH (mean pulmonary artery pressure (mPAP)>20mmHg) were retrospectively identified...
September 21, 2023: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/37726865/evaluation-of-safety-and-efficacy-of-allogeneic-adipose-tissue-derived-mesenchymal-stem-cells-in-pediatric-bronchiolitis-obliterans-syndrome-bos-after-allogeneic-hematopoietic-stem-cell-transplantation-allo-hsct
#27
JOURNAL ARTICLE
Rashin Mohseni, Pouya Mahdavi Sharif, Maryam Behfar, Mohammad Reza Modaresi, Rohola Shirzadi, Mahta Mardani, Leila Jafari, Fahimeh Jafari, Zeynab Nikfetrat, Amir Ali Hamidieh
BACKGROUND: Allo-HSCT is a definite approach for the management of a wide variety of lethal and debilitating malignant and non-malignant disorders. However, its two main complications, acute and chronic graft-versus-host disease (GVHD), exert significant morbidities and mortalities. BoS, as a manifestation of chronic lung GVHD, is a gruesome complication of allo-HSCT, and for those with steroid-refractory disease, no approved second-line therapies exist. Mesenchymal stem cells (MSCs) exert anti-inflammatory and growth-promoting effects, and their administration against a wide range of inflammatory and neurologic disorders, as well as GVHD, has been associated with promising outcomes...
September 19, 2023: Stem Cell Research & Therapy
https://read.qxmd.com/read/37715611/telocytes-protect-against-lung-tissue-fibrosis-through-hexokinase-2-dependent-pathway-by-secreting-hepatocyte-growth-factor
#28
JOURNAL ARTICLE
Shaoyuan Zhang, Linyi Sun, Borong Chen, Siyun Lin, Jianmin Gu, Lijie Tan, Miao Lin
Pulmonary fibrosis (PF) is one of the common manifestations of end-stage lung disease. Chronic lung failure after lung transplantation is mainly caused by bronchiolitis obliterans syndrome (BOS) and is mainly characterized by lung tissue fibrosis. Pulmonary epithelial-mesenchymal transformation (EMT) is crucial for pulmonary fibrosis. Telocytes (TCs), a new type of mesenchymal cells, play a protective role in various acute injuries. For exploring the anti-pulmonary fibrosis effect of TCs in the BOS model in vitro and the related mechanism, rat tracheal epithelial (RTE) cells were treated with transforming growth factor-β (TGF-β) to simulate lung tissue fibrosis in vitro...
September 16, 2023: Clinical and Experimental Pharmacology & Physiology
https://read.qxmd.com/read/37713011/successful-management-of-temporary-veno-venous-extracorporeal-membrane-oxygenation-for-a-pediatric-lung-transplant-recipient-with-bronchiolitis-obliterans-syndrome-awaiting-lung-re-transplantation-a-case-report
#29
JOURNAL ARTICLE
Yasuaki Tomioka, Kentaroh Miyoshi, Shin Tanaka, Seiichiro Sugimoto, Rie Kanai, Tetsuro Nikai, Shinichi Toyooka, Masaomi Yamane
BACKGROUND: The use of extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation is an uncommon strategy in Japan owing to the severe donor shortage and absence of urgent allocation policy. Moreover, the use of veno-venous (VV) ECMO for immunosuppressed patients is controversial; thus, applying ECMO to patients who await lung re-transplantation is challenging. CASE PRESENTATION: A 16-year-old lung transplant recipient with grade 3 bronchiolitis obliterans syndrome was waitlisted for lung re-transplantation...
September 15, 2023: Surgical Case Reports
https://read.qxmd.com/read/37696312/efficacy-of-inhaled-tiotropium-add-on-to-budesonide-formoterol-in-patients-with-bronchiolitis-obliterans-developing-after-hematopoietic-stem-cell-transplantation
#30
JOURNAL ARTICLE
Jeong Uk Lim, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chin Kook Rhee
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is the lung manifestation of chronic graft-versus-host disease after hematopoietic stem cell transplantation (HSCT). We assessed whether inhaled tiotropium add-on to the combination regimen including budesonide/formoterol improve pulmonary function and the chronic obstructive pulmonary disease assessment test (CAT) scores in patients with BOS. METHODS: Post-HSCT patients diagnosed as BOS in Seoul St. Mary's Hospital were reviewed retrospectively...
September 9, 2023: Respiratory Medicine
https://read.qxmd.com/read/37673192/paraneoplastic-autoimmune-laminin-332-syndrome-pals-anti-laminin-332-mucous-membrane-pemphigoid-as-a-prototype
#31
REVIEW
A Razzaque Ahmed, Mikole Kalesinskas, Sarah Kooper-Johnson
IMPORTANCE: Laminin-332 is an important component of the basement membrane. Recently, autoantibodies to Laminin-332 have been described in several autoimmune diseases. Many of these autoimmune diseases have a high incidence of malignancy. The importance of Laminin-332 autoantibodies and its relationship to malignancy is highlighted by using Laminin-332 Pemphigoid (LM-332Pg) as a prototype. OBJECTIVE: To identify several autoimmune diseases that have autoantibodies to Laminin-332 present, and to determine the prevalence of malignancy in them...
September 4, 2023: Autoimmunity Reviews
https://read.qxmd.com/read/37656927/impact-of-gastro-jejunostomy-tube-in-lung-transplant-patients-a-propensity-matched-analysis
#32
JOURNAL ARTICLE
Masashi Furukawa, Ernest G Chan, John P Ryan, Jenalee N Coster, Pablo G Sanchez
OBJECTIVES: During the postoperative phase of lung transplantation, the surgical creation of a gastro-jejunostomy may be deemed necessary for patients with severe esophageal dysmotility, prolonged oral intake difficulties stemming from use of a ventilator or marked malnutrition. We explored the effects of postoperative gastro-jejunostomy tube on survival and bronchiolitis obliterans syndrome in lung transplant recipients. METHODS: We retrospectively reviewed all lung transplants performed at our institution between 2011 and 2022...
September 1, 2023: Interdiscip Cardiovasc Thorac Surg
https://read.qxmd.com/read/37597771/paraneoplastic-pemphigus-paraneoplastic-autoimmune-multiorgan-syndrome-part-i-clinical-overview-and-pathophysiology
#33
REVIEW
Hannah J Anderson, Simo Huang, Jason B Lee
Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome (PNP/PAMS) is a highly fatal autoimmune blistering disease. The condition occurs in patients with underlying benign or malignant neoplasms, most commonly lymphoproliferative disorders. Both humoral and cell-mediated immunities contribute to the pathogenesis, and autoantibodies against plakin family proteins are characteristic. Patients typically present with severe stomatitis and polymorphous skin lesions, which are often resistant to treatment...
August 17, 2023: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/37523071/restrictive-allograft-dysfunction-rather-than-bronchiolitis-obliterans-syndrome-had-a-major-impact-on-the-overall-survival-after-living-donor-lobar-lung-transplantation
#34
JOURNAL ARTICLE
Kei Matsubara, Shinji Otani, Haruchika Yamamoto, Kohei Hashimoto, Shin Tanaka, Kazuhiko Shien, Ken Suzawa, Kentaroh Miyoshi, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka
PURPOSE: Chronic lung allograft dysfunction (CLAD) is a known long-term fatal disorder after lung transplantation. In this study, we evaluated the CLAD classification of the International Society for Heart and Lung Transplantation (ISHLT) for living-donor lobar lung transplantation (LDLLT). METHODS: We conducted a single-center retrospective review of data from 73 patients who underwent bilateral LDLLT between 1998 and 2019. Factors related to opacity on computed tomography (CT) and restriction on pulmonary function tests (PFTs) were also analyzed...
July 31, 2023: Surgery Today
https://read.qxmd.com/read/37495291/imaging-in-lung-transplantation-surgical-techniques-and-complications
#35
REVIEW
Jiyoon Kang, Subba R Digumarthy
Lung transplant is an established treatment for patients with end-stage lung disease. As a result, there is increased demand for transplants. Despite improvements in pretransplant evaluation, surgical techniques, and postsurgical care, the average posttransplant life expectancy is only around 6.5 years. Early recognition of complications on imaging and treatment can improve survival. Knowledge of surgical techniques and imaging findings of surgical and nonsurgical complications is essential. This review covers surgical techniques and imaging appearance of postsurgical and nonsurgical complications, including allograft dysfunction, infections, neoplasms, and recurrence of primary lung disease...
September 2023: Radiologic Clinics of North America
https://read.qxmd.com/read/37476615/pediatric-adenovirus-pneumonia-clinical-practice-and-current-treatment
#36
REVIEW
Jie Zhang, Yiting Zhu, Yiyang Zhou, Fei Gao, Xinhui Qiu, Jianshun Li, Hao Yuan, Wenwen Jin, Wei Lin
Adenovirus pneumonia is common in pediatric upper respiratory tract infection, which is comparatively easy to develop into severe cases and has a high mortality rate with many influential sequelae. As for pathogenesis, adenoviruses can directly damage target cells and activate the immune response to varying degrees. Early clinical recognition depends on patients' symptoms and laboratory tests, including those under 2 years old, dyspnea with systemic toxic symptoms, atelectasis or emphysema in CT image, decreased leukocytes, and significantly increased C-reaction protein (CRP) and procalcitonin (PCT), indicating the possibility of severe cases...
2023: Frontiers in Medicine
https://read.qxmd.com/read/37461238/percentage-of-low-attenuation-area-on-computed-tomography-detects-chronic-lung-allograft-dysfunction-especially-bronchiolitis-obliterans-syndrome-after-bilateral-lung-transplantation
#37
JOURNAL ARTICLE
Yujiro Kubo, Seiichiro Sugimoto, Toshio Shiotani, Kei Matsubara, Kohei Hashimoto, Shin Tanaka, Kazuhiko Shien, Ken Suzawa, Kentaroh Miyoshi, Hiromasa Yamamoto, Mikio Okazaki, Shinichi Toyooka
INTRODUCTION: The percentage of low attenuation area (%LAA) on computed tomography (CT) is useful for evaluating lung emphysema, and higher %LAA was observed in patients with chronic lung allograft dysfunction (CLAD). This study investigated the relationship between the %LAA and the development of CLAD after bilateral lung transplantation (LT). METHODS: We conducted a single-center retrospective study of 75 recipients who underwent bilateral LT; the recipients were divided into a CLAD group (n = 30) and a non-CLAD group (n = 45)...
July 17, 2023: Clinical Transplantation
https://read.qxmd.com/read/37443465/worldwide-bronchiolitis-obliterans-research-a-bibliometric-analysis-of-the-published-literature-between-2002-and-2022
#38
JOURNAL ARTICLE
Zhengjiu Cui, Xu Zhou, Fei Luo, Jinjuan Wang, Juanjuan Diao, Yueli Pan
Bronchiolitis obliterans (BO) is a rare and irreversible chronic respiratory disease. The diagnosis of BO is challenging, and there still needs to be specific therapies and uniform treatment guidelines available. Research on BO has grown steadily over the past 20 years, and with the continued interest of researchers in this area, a bibliometric study of BO becomes necessary. This topic aims to assess the current state of research in BO over the last 2 decades and to identify research hotspots and emerging directions...
July 14, 2023: Medicine (Baltimore)
https://read.qxmd.com/read/37443411/can-we-see-clearly-now-computed-tomography-for-bronchiolitis-obliterans-syndrome-prognostication
#39
JOURNAL ARTICLE
Anil J Trindade
No abstract text is available yet for this article.
July 14, 2023: Transplantation
https://read.qxmd.com/read/37402896/collagen-type-iv-alpha-5-chain-in-bronchiolitis-obliterans-syndrome-after-lung-transplant-the-first-evidence
#40
JOURNAL ARTICLE
M Armati, S Cattelan, M Guerrieri, M Messina, B Perea, M Genovese, M d'Alessandro, S Gangi, P Cameli, F Perillo, D Bennett, A Fossi, E Bargagli, L Bergantini
INTRODUCTION: Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airflow limitation and an obstructive spirometry pattern without parenchymal opacities. The protein signature of BOS lesions concerns extracellular matrix organization and aberrant basement membrane composition. In this pilot study, we investigated the presence of COL4A5 in the serum of patients with BOS. METHODS: 41 patients who had undergone LTX were enrolled...
July 4, 2023: Lung
keyword
keyword
22096
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.